Cost Effectiveness of Cladribine Tablets for the Treatment of Relapsing-Remitting Multiple Sclerosis in The Netherlands

BACKGROUND: Cladribine tablets have recently become available in The Netherlands for patients with relapsing–remitting multiple sclerosis (RRMS) as a disease-modifying agent that reduces the frequency and severity of relapses and delays disability progression. OBJECTIVE: The aim of this study was to...

詳細記述

保存先:
書誌詳細
出版年:Appl Health Econ Health Policy
主要な著者: Michels, Renée Else, de Fransesco, Maria, Mahajan, Koshu, Hengstman, Gerald J. D., Schiffers, Krijn M. H., Budhia, Sangeeta, Harty, Gerard, Krol, Marieke
フォーマット: Artigo
言語:Inglês
出版事項: Springer International Publishing 2019
主題:
Original Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885501/
https://ncbi.nlm.nih.gov/pubmed/31444659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40258-019-00500-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料